Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epigenetic Modification in OPRM1 and Sufentanil Analgesia
NCT03135795Phase 4Unknown
- Sponsor
- Huazhong University of Science and Technology
- Start
- Feb 2017
- Primary completion
- May 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sufentanil in postoperative pain, sponsored by Huazhong University of Science and Technology. Primary endpoint: Quantification of methylation in CpG islands located in gene OPRM1 at 3 months. Status: unknown.
02
Drugs
sufentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03135795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03135795.